USANA Health Sciences (USNA) Key Ratios
$14.83
As on 09-Sep-2026 13:40EDT
Market cap
$267 Mln
Revenue (TTM)
$913 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -10.77 | -5.33 | 1.57 | -1.23 | -6.14 |
| EBIT | -- | -- | -66.61 | -40.06 | -35.63 |
| Net Profit | -384.52 | -341.17 | -166.56 | -170.49 | -169.29 |
| EPS | -383.37 | -322.06 | -166.63 | -171.55 | -171.06 |
| Book Value | -- | -- | 4.58 | 8.90 | 6.92 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| 8.23 | 9.96 | 2.39 | 4.58 | 8.97 |
| Net Margin
| -- | 9.82 | -2.43 | -- | -- |
| Return on equity
| 7.96 | 13.69 | -4.19 | 2.02 | 8.17 |
| Return on Capital
| 7.67 | 13.15 | -- | 1.92 | 7.77 |
| Return on Assets
| 5.97 | 9.77 | -2.41 | 1.44 | 6.09 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.03 | 0.07 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
1.92
|
7.77
|
13.31
|
16.12
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-4.19
Lower than Peers by 13.62
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
-4.19
|
2.02
|
8.17
|
13.69
|
16.72
|
|
Peer Median
|
9.42
|
--
|
--
|
--
|
--
|
ROA
-2.41
Lower than Peers by 5.81
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
-2.41
|
1.44
|
6.09
|
10.38
|
11.81
|
|
Peer Median
|
3.40
|
--
|
--
|
--
|
--
|
EBIT Margin
2.39
Lower than Peers by 6.17
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
2.39
|
4.58
|
8.97
|
11.15
|
10.78
|
|
Peer Median
|
8.56
|
--
|
--
|
--
|
--
|
Net Margin
-2.43
Lower than Peers by 7.21
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
-2.43
|
1.16
|
4.92
|
6.93
|
6.94
|
|
Peer Median
|
4.78
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
1.57
Higher than Peers by 1.03
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
1.57
|
0.08
|
-0.07
|
-0.08
|
-0.16
|
|
Peer Median
|
0.54
|
--
|
--
|
--
|
--
|
EBIT Growth
-66.61
Lower than Peers by 64.90
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
-66.61
|
-44.71
|
-25.39
|
-4.55
|
-36.77
|
|
Peer Median
|
-1.72
|
--
|
--
|
--
|
--
|
Net Profit Growth
-166.56
Lower than Peers by 163.90
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
-166.56
|
-74.40
|
-34.11
|
-8.02
|
-40.47
|
|
Peer Median
|
-2.66
|
--
|
--
|
--
|
--
|
EPS Growth
-166.63
Lower than Peers by 189.13
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
-166.63
|
-0.73
|
-0.34
|
-0.08
|
-0.39
|
|
Peer Median
|
22.51
|
--
|
--
|
--
|
--
|
Book Value Growth
-0.63
Lower than Peers by 8.44
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
-0.63
|
--
|
--
|
--
|
--
|
|
Peer Median
|
7.81
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
0.03
|
0.07
|
0.03
|
0.03
|
|
Peer Median
|
0.67
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
0.03
|
0.05
|
0.02
|
0.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.66
Higher than Peers by 1.10
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
2.66
|
2.24
|
2.00
|
3.52
|
2.65
|
|
Peer Median
|
1.56
|
--
|
--
|
--
|
--
|
Quick Ratio
1.84
Higher than Peers by 1.02
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
1.84
|
1.45
|
1.50
|
3.00
|
2.18
|
|
Peer Median
|
0.82
|
--
|
--
|
--
|
--
|
Interest Coverage
7.16
Higher than Peers by 2.85
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
7.16
|
50.32
|
272.71
|
392.04
|
560.49
|
|
Peer Median
|
4.31
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
0.37
Lower than Peers by 8.37
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
0.37
|
--
|
0.96
|
0.78
|
0.72
|
|
Peer Median
|
8.74
|
--
|
--
|
--
|
--
|
Asset Turnover
0.99
Higher than Peers by 0.34
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
0.99
|
1.24
|
1.24
|
1.50
|
1.70
|
|
Peer Median
|
0.65
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
3.25
|
3.30
|
2.86
|
2.63
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
156.70
|
136.32
|
123.95
|
155.80
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
26.59
|
22.92
|
20.36
|
23.13
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
133.36
|
116.70
|
106.44
|
135.30
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
33.39
|
16.31
|
16.18
|
14.78
|
|
Peer Median
|
22.53
|
--
|
--
|
--
|
--
|
Price / Book Value
0.49
Lower than Peers by 1.29
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
0.49
|
0.67
|
1.29
|
2.08
|
2.36
|
|
Peer Median
|
1.78
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2.62
|
--
|
--
|
--
|
--
|
EV/EBITDA
2.61
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
2.61
|
2.62
|
5.49
|
5.81
|
5.81
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
267
Lower than Peers by 375
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
267
|
--
|
--
|
--
|
--
|
|
Peer Median
|
641
|
--
|
--
|
--
|
--
|